Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis

Overview

Journal Hemasphere

Publisher Wiley

Specialty Hematology

Date 2022 Aug 8

PMID 35935609

Authors

Somayya Noori

Marina Zajec

Henk Russcher

Andrei N Tintu

Annemiek Broijl

Joannes F M Jacobs

Theo M Luider

Yolanda B de Rijke

Martijn M VanDuijn

Affiliations

Soon will be listed here.

Citing Articles

M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.

Wijnands C, Langerhorst P, Noori S, Keizer-Garritsen J, Wessels H, Gloerich J Clin Chem Lab Med. 2023; 62(3):540-550.

PMID: 37823394 PMC: 10808047. DOI: 10.1515/cclm-2023-0781.

Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study.

Peng W, den Boer M, Tamara S, Mokiem N, van der Lans S, Bondt A J Proteome Res. 2023; 22(9):3022-3028.

PMID: 37499263 PMC: 10476240. DOI: 10.1021/acs.jproteome.3c00330.

References

McDonald Z, Taylor P, Liyasova M, Liu Q, Ma B . Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients. J Proteome Res. 2021; 20(8):4176-4185. DOI: 10.1021/acs.jproteome.0c01022. View

Willrich M, Murray D, Kyle R . Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Clin Biochem. 2017; 51:38-47. DOI: 10.1016/j.clinbiochem.2017.05.001. View

Zajec M, Jacobs J, de Kat Angelino C, Dekker L, Stingl C, Luider T . Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and Quantification. J Proteome Res. 2020; 19(7):2845-2853. DOI: 10.1021/acs.jproteome.9b00705. View

Zajec M, Jacobs J, Groenen P, de Kat Angelino C, Stingl C, Luider T . Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies. J Proteome Res. 2018; 17(3):1326-1333. DOI: 10.1021/acs.jproteome.7b00890. View

Moreau P, Attal M, Facon T . Frontline therapy of multiple myeloma. Blood. 2015; 125(20):3076-84. DOI: 10.1182/blood-2014-09-568915. View

Mills J, Barnidge D, Murray D . Detecting monoclonal immunoglobulins in human serum using mass spectrometry. Methods. 2015; 81:56-65. DOI: 10.1016/j.ymeth.2015.04.020. View

Jacobs J, Turner K, Graziani M, Frinack J, Ettore M, Tate J . An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins. Clin Chem Lab Med. 2020; 58(4):547-559. DOI: 10.1515/cclm-2019-1105. View

Dimopoulos M, Kyle R, Fermand J, Rajkumar S, San Miguel J, Chanan-Khan A . Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood. 2011; 117(18):4701-5. DOI: 10.1182/blood-2010-10-299529. View

Bonilla F . Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes. Immunol Allergy Clin North Am. 2008; 28(4):803-19, ix. DOI: 10.1016/j.iac.2008.06.006. View

10.

Santockyte R, Jin C, Pratt J, Ammar R, Desai K, Bolisetty M . Sensitive multiple myeloma disease monitoring by mass spectrometry. Blood Cancer J. 2021; 11(4):78. PMC: 8084958. DOI: 10.1038/s41408-021-00473-9. View

11.

Vyatkina K . De Novo Sequencing of Top-Down Tandem Mass Spectra: A Next Step towards Retrieving a Complete Protein Sequence. Proteomes. 2017; 5(1). PMC: 5372227. DOI: 10.3390/proteomes5010006. View

12.

Murray D, Dasari S . Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis. Clin Lab Med. 2021; 41(2):203-219. DOI: 10.1016/j.cll.2021.03.003. View

13.

Martins C, Huet S, Yi S, Ritorto M, Landgren O, Dogan A . Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma. J Mol Diagn. 2020; 22(7):901-911. PMC: 7338887. DOI: 10.1016/j.jmoldx.2020.04.002. View

14.

Kumar S, Paiva B, Anderson K, Durie B, Landgren O, Moreau P . International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016; 17(8):e328-e346. DOI: 10.1016/S1470-2045(16)30206-6. View

15.

Pino L, Searle B, Bollinger J, Nunn B, MacLean B, MacCoss M . The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics. Mass Spectrom Rev. 2017; 39(3):229-244. PMC: 5799042. DOI: 10.1002/mas.21540. View